• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Enhancement of dissolution profile by solid dispersion (kneading) technique.采用固体分散体(捏合)技术提高溶出度曲线
AAPS PharmSciTech. 2006 Aug 18;7(3):68. doi: 10.1208/pt070368.
2
Preparation, characterization and tableting of cilnidipine solid dispersions.西尼地平固体分散体的制备、表征及压片
Pak J Pharm Sci. 2013 May;26(3):629-36.
3
Effect of drug-carrier interaction on the dissolution behavior of solid dispersion tablets.载药相互作用对固体分散体片溶出行为的影响。
Pharm Dev Technol. 2010 Sep-Oct;15(5):460-8. doi: 10.3109/10837450903286529.
4
Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000.使用聚乙二醇4000固体分散体提高伐地考昔的溶出速率。
Drug Dev Ind Pharm. 2005 Jan;31(1):1-10. doi: 10.1081/ddc-43918.
5
Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.含罗非昔布固体分散体的口腔崩解片的处方设计与优化
AAPS PharmSciTech. 2006 Jun 16;7(2):E55. doi: 10.1208/pt070255.
6
QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.采用 QbD 方法制备速崩片,其中包含吲哚美辛固体分散体。
Pharm Dev Technol. 2011 Jun;16(3):219-27. doi: 10.3109/10837451003592209. Epub 2010 Feb 18.
7
Physicochemical characterization and dissolution study of solid dispersions of Lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30.洛伐他汀与聚乙二醇4000和聚乙烯吡咯烷酮K30固体分散体的物理化学表征及溶出度研究
Pharm Dev Technol. 2007;12(1):21-33. doi: 10.1080/10837450601166510.
8
Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.通过包合络合和固体分散技术提高拉莫三嗪的溶解度和溶出速率。
J Pharm Pharmacol. 2008 Sep;60(9):1121-9. doi: 10.1211/jpp.60.9.0002.
9
Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.含储存和压缩稳定剂的无定形塞来昔布喷雾干燥共沉淀物的研制
Acta Pharm. 2007 Sep;57(3):287-300. doi: 10.2478/v10007-007-0023-7.
10
In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier.采用聚维酮作为载体的瑞格列奈新型固体分散体的体内外研究。
Drug Dev Ind Pharm. 2012 Nov;38(11):1371-80. doi: 10.3109/03639045.2011.652635. Epub 2012 Feb 2.

引用本文的文献

1
Preparation and characterization of naproxen solid dispersion using different hydrophilic carriers and in-vivo evaluation of its analgesic activity in mice.使用不同亲水性载体制备萘普生固体分散体及其在小鼠体内的镇痛活性评价
Heliyon. 2023 Apr 26;9(5):e15432. doi: 10.1016/j.heliyon.2023.e15432. eCollection 2023 May.
2
Formulation and evaluation of fast dissolving tablets of haloperidol solid dispersion.氟哌啶醇固体分散体速溶片的处方设计与评价
Saudi Pharm J. 2022 Nov;30(11):1589-1602. doi: 10.1016/j.jsps.2022.09.002. Epub 2022 Sep 9.
3
Nanocrystallization Improves the Solubilization and Cytotoxic Effect of a Poly (ADP-Ribose)-Polymerase-I Inhibitor.纳米晶化改善聚(ADP - 核糖)聚合酶 - I抑制剂的溶解性和细胞毒性作用。
Polymers (Basel). 2022 Nov 9;14(22):4827. doi: 10.3390/polym14224827.
4
Formulation and Quality Control of Orally Disintegrating Tablets (ODTs): Recent Advances and Perspectives.口服速崩片(ODTs)的制剂与质量控制:最新进展与展望。
Biomed Res Int. 2021 Dec 24;2021:6618934. doi: 10.1155/2021/6618934. eCollection 2021.
5
Preparation and characterisation of solid dispersions of tanshinone IIA, cryptotanshinone and total tanshinones.丹参酮IIA、隐丹参酮及丹参总酮固体分散体的制备与表征
Asian J Pharm Sci. 2017 Jan;12(1):85-97. doi: 10.1016/j.ajps.2016.08.004. Epub 2016 Aug 31.
6
Development of a Ternary Solid Dispersion Formulation of LW6 to Improve the In Vivo Activity as a BCRP Inhibitor: Preparation and In Vitro/In Vivo Characterization.LW6三元固体分散体配方的研发以提高其作为BCRP抑制剂的体内活性:制备及体外/体内表征
Pharmaceutics. 2019 May 1;11(5):206. doi: 10.3390/pharmaceutics11050206.
7
Silymarin-laden PVP-PEG polymeric composite for enhanced aqueous solubility and dissolution rate: Preparation and in vitro characterization.用于提高水溶性和溶解速率的载水飞蓟素PVP-PEG聚合物复合材料:制备与体外表征
J Pharm Anal. 2019 Feb;9(1):34-39. doi: 10.1016/j.jpha.2018.09.003. Epub 2018 Sep 19.
8
dissolution and bioavailability study of furosemide nanosuspension prepared using design of experiment (DoE).采用实验设计(DoE)制备的速尿纳米混悬液的溶出度和生物利用度研究。
Saudi Pharm J. 2019 Jan;27(1):96-105. doi: 10.1016/j.jsps.2018.09.002. Epub 2018 Sep 3.
9
Formulation and clinical investigation of optimized vinpocetine lyoplant-tabs: new strategy in development of buccal solid dosage form.优化长春西汀冻干片的处方设计与临床研究:口腔固体制剂开发的新策略
Drug Des Devel Ther. 2018 Dec 28;13:205-220. doi: 10.2147/DDDT.S189105. eCollection 2019.
10
Optimization of the Factors Affecting the Absorption of Vardenafil from Oral Disintegrating Tablets: A Clinical Pharmacokinetic Investigation.伐地那非口腔崩解片吸收影响因素的优化:一项临床药代动力学研究。
Pharmaceutics. 2019 Jan 1;11(1):11. doi: 10.3390/pharmaceutics11010011.

本文引用的文献

1
Establishment of new preparation method for solid dispersion formulation of tacrolimus.他克莫司固体分散体制剂新制备方法的建立。
Int J Pharm. 2003 Nov 28;267(1-2):79-91. doi: 10.1016/j.ijpharm.2003.07.010.
2
Nimesulide-modified gum karaya solid mixtures: preparation, characterization, and formulation development.尼美舒利改性刺梧桐树胶固体混合物:制备、表征及处方开发
Drug Dev Ind Pharm. 2003 Sep;29(8):855-64. doi: 10.1081/ddc-120024181.
3
Characterization and solubility study of solid dispersions of flunarizine and polyvinylpyrrolidone.氟桂利嗪与聚乙烯吡咯烷酮固体分散体的表征及溶解度研究
Farmaco. 2002 Sep;57(9):723-7. doi: 10.1016/s0014-827x(02)01262-4.
4
Solid-state characterization of nifedipine solid dispersions.硝苯地平固体分散体的固态表征
Int J Pharm. 2002 Apr 2;236(1-2):111-23. doi: 10.1016/s0378-5173(02)00019-4.
5
Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine.评价改性刺梧桐树胶作为载体对难溶性药物尼莫地平溶出度的增强作用。
Int J Pharm. 2002 Mar 2;234(1-2):1-17. doi: 10.1016/s0378-5173(01)00925-5.
6
Improvement of dissolution and oral absorption of ER-34122, a poorly water-soluble dual 5-lipoxygenase/cyclooxygenase inhibitor with anti-inflammatory activity by preparing solid dispersion.通过制备固体分散体改善ER-34122(一种具有抗炎活性的难溶性双5-脂氧合酶/环氧化酶抑制剂)的溶出度和口服吸收。
J Pharm Sci. 2002 Jan;91(1):258-66. doi: 10.1002/jps.10020.
7
Characterization and evaluation of tenoxicam coprecipitates.替诺昔康共沉淀物的表征与评价
Drug Dev Ind Pharm. 2000 Sep;26(9):925-30. doi: 10.1081/ddc-100101319.
8
Solubilization and interaction of sulindac with polyvinylpyrrolidone K30 in the solid state and in aqueous solution.舒林酸与聚乙烯吡咯烷酮K30在固态及水溶液中的增溶作用与相互作用。
Drug Dev Ind Pharm. 1998 Mar;24(3):295-300. doi: 10.3109/03639049809085623.
9
Pharmaceutical applications of solid dispersion systems.固体分散体系统的药物应用。
J Pharm Sci. 1971 Sep;60(9):1281-302. doi: 10.1002/jps.2600600902.
10
The current status of solid dispersions.固体分散体的现状
Pharm Acta Helv. 1986;61(3):69-88.

采用固体分散体(捏合)技术提高溶出度曲线

Enhancement of dissolution profile by solid dispersion (kneading) technique.

作者信息

Modi Aftab, Tayade Pralhad

机构信息

Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai-400 098, India.

出版信息

AAPS PharmSciTech. 2006 Aug 18;7(3):68. doi: 10.1208/pt070368.

DOI:10.1208/pt070368
PMID:17025249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2750510/
Abstract

This article investigates enhancement of the dissolution profile of valdecoxib using solid dispersion with PVP. The article also describes the preparation of fast-dissolving tablets of valdecoxib by using a high amount of superdisintegrants. A phase solubility method was used to evaluate the effect of various water-soluble polymers on aqueous solubility of valdecoxib. Polyvinyl pyrrolidone (PVP K-30) was selected and solid dispersions were prepared by the method of kneading. Dissolution studies using the USP paddle method were performed for solid dispersions of valdecoxib. Infrared (IR) spectroscopy, differential scanning calorimetry (DSC), and x-ray diffractometry (XRD) were performed to identify the physicochemical interaction between drug and carrier, hence its effect on dissolution. Tablets were formulated containing solid dispersion products and compared with commercial products. IR spectroscopy, XRD, and DSC showed no change in the crystal structure of valdecoxib. Dissolution of valdecoxib improved significantly in solid dispersion products (< 85% in 5 minutes). Tablets containing solid dispersion exhibited better dissolution profile than commercial tablets. Thus, the solid dispersion technique can be successfully used for improvement of dissolution of valdecoxib.

摘要

本文研究了使用聚乙烯吡咯烷酮(PVP)固体分散体提高伐地考昔的溶出曲线。本文还描述了通过使用大量超级崩解剂制备伐地考昔速溶片的方法。采用相溶解度法评估各种水溶性聚合物对伐地考昔水溶性的影响。选择聚乙烯吡咯烷酮(PVP K-30),并通过捏合法制备固体分散体。采用美国药典桨法对伐地考昔固体分散体进行溶出度研究。进行红外(IR)光谱、差示扫描量热法(DSC)和X射线衍射法(XRD)以确定药物与载体之间的物理化学相互作用,从而确定其对溶出的影响。制备含有固体分散体产品的片剂,并与市售产品进行比较。IR光谱、XRD和DSC显示伐地考昔的晶体结构没有变化。伐地考昔在固体分散体产品中的溶出度显著提高(5分钟内<85%)。含有固体分散体的片剂比市售片剂表现出更好的溶出曲线。因此,固体分散技术可成功用于改善伐地考昔的溶出度。